First day of trading in Cinclus Pharma’s ordinary shares on Nasdaq Stockholm
Today marks the first day of trading in Cinclus Pharma’s ordinary shares on Nasdaq Stockholm.
Read more
News
Check out the latest news from Cinclus Pharma
Strong interest in the listing - interview with CEO Christer Ahlberg
CEO of Cinclus Pharma, Christer Ahlberg, talks about the strong interest in the listing in an interview with Realtid.
Read more
Interview with Cinclus Pharma's CEO Christer Ahlberg in Börslunch on the upcoming listing
Here you can see the full interview (in Swedish) with Cinclus Pharma's CEO Christer Ahlberg in today's Börslunch of EFN Ekonomikanalen where he answers questions ahead of the upcoming listing.
Read more